Amarin Corp Adr (AMRN)

Amarin Corp Adr 주식(AMRN)의 최신 뉴스

Oct 29, 2026

Amarin's Q3 Earnings Beat Estimates, Revenues Miss Mark - Zacks Investment Research

Oct 29, 2026

Oct 27, 2026

Amarin (AMRN) Set to Report Q3 Earnings Amid Price-to-Sales Valu - GuruFocus

Oct 27, 2026

Oct 26, 2026

Amarin Corporation PLC expected to post a loss of 2 cents a share - Earnings Preview - TradingView

Oct 26, 2026

Oct 25, 2026

Amarin’s icosapent ethyl shows survival benefit in cancer trial - Investing.com

Oct 25, 2026

Oct 25, 2026

Amarin Highlights EMT2 Phase 3 Trial Showing Overall Survival Benefit for VAZKEPA/VASCEPA in Colorectal Cancer Liver Metastases - Quiver Quantitative

Oct 25, 2026

Oct 25, 2026

Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal - The Manila Times

Oct 25, 2026

Oct 25, 2026

A colorectal cancer trial missed its goal, but estimated 5-year survival was 62% with the drug versus 45% with placebo. - Stock Titan

Oct 25, 2026

Oct 25, 2026

Amarin’s icosapent ethyl shows survival benefit in cancer trial By Investing.com - Investing.com UK

Oct 25, 2026

Oct 23, 2026

Amarin Corporation Plc Sponsored ADR Estimates – SWB:EH3 - TradingView

Oct 23, 2026

Oct 21, 2026

Amarin Announces Date for Third Quarter 2026 Financial Results Conference Call - Moomoo

Oct 21, 2026

Oct 21, 2026

Amarin Announces Date for Third Quarter 2026 Financial Results Conference Call - Quiver Quantitative

Oct 21, 2026

Oct 21, 2026

Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026 - Yahoo Finance

Oct 21, 2026

Oct 21, 2026

Third-quarter results are due before market hours Oct. 28, followed by Amarin's 8 a.m. ET call. - Stock Titan

Oct 21, 2026

Oct 17, 2026

Amarin Q2 2026 Earnings: $0.04 Per Share Swings to Profit, Beating Estimates by 492% - EBITDA Analysis - https://www.dars.gov.et/

Oct 17, 2026

Oct 17, 2026

Amarin Q2 2026 Earnings: $0.04 Per Share Swings to Profit, Beating Estimates by 492% - Preliminary Results - https://www.dars.gov.et/

Oct 17, 2026

Oct 15, 2026

FDA Expands ImmunityBio's Anktiva Label in Bladder Cancer - Zacks Investment Research

Oct 15, 2026

Oct 15, 2026

Here's Why You Should Add EYPT Stock to Your Portfolio Now - Zacks Investment Research

Oct 15, 2026

Oct 15, 2026

RARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a Week - Zacks Investment Research

Oct 15, 2026

Oct 14, 2026

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Zacks Investment Research

Oct 14, 2026

Oct 14, 2026

Here's Why You Should Add ANRO Stock to Your Portfolio Now - Zacks Investment Research

Oct 14, 2026

Oct 14, 2026

Syndax Stock Falls 16% as Phase II Fibrosis Study Misses Primary Goal - Zacks Investment Research

Oct 14, 2026

Oct 13, 2026

BMY Reports Mixed Phase III Trial Results, Stock Down - Zacks Investment Research

Oct 13, 2026

Oct 12, 2026

Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why - Zacks Investment Research

Oct 12, 2026

Oct 12, 2026

PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know - Zacks Investment Research

Oct 12, 2026

Oct 09, 2026

argenx Meets Primary Endpoint in Phase II Celiac Disease Study - Zacks Investment Research

Oct 09, 2026

Oct 09, 2026

EDIT Set to Begin First-in-Human Study in Hypercholesterolemia - Zacks Investment Research

Oct 09, 2026

Oct 09, 2026

argenx Meets Primary Endpoint in Phase II Celiac Disease Study - TradingView

Oct 09, 2026

Oct 08, 2026

Here's Why You Should Add LPCN Stock to Your Portfolio Now - Zacks Investment Research

Oct 08, 2026

Oct 07, 2026

ETON Stock Surges 108% in Six Months: Here's What You Need to Know - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Amarin (AMRN) Slips 2.11% to $12.09 as Shares Test Lower End of Recent Range - Corrective Wave - https://www.siam.in/

Oct 06, 2026

Oct 03, 2026

Amarin Corporation (AMRN) Slips 2.91% to $12.35 as Traders Eye Support at $11.73 - Diagonal Spread Trade - https://www.dars.gov.et/

Oct 03, 2026

Oct 01, 2026

Amarin Corporation plc (AMRN) Options Chain - Yahoo! Finance Canada

Oct 01, 2026

Oct 01, 2026

Amarin Corporation plc (AMRN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 01, 2026

Oct 01, 2026

Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study - Zacks Investment Research

Oct 01, 2026

Sep 25, 2026

Amarin Stock Price Forecast. Should You Buy AMRN? - StockInvest.us

Sep 25, 2026

Sep 24, 2026

Amarin Corporation plc (AMRN) Options Chain - Yahoo Finance - Yahoo! Finance Canada

Sep 24, 2026

Sep 24, 2026

Amarin Corporation plc (AMRN) Options Chain - Yahoo Finance - Yahoo! Finance Canada

Sep 24, 2026

Sep 10, 2026

Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report? - Zacks Investment Research

Sep 10, 2026

Sep 09, 2026

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Sep 09, 2026

Aug 31, 2026

Amarin Highlights New ESC 2026 Data and Guideline Support Reinforcing Evidence for Icosapent Ethyl - Quiver Quantitative

Aug 31, 2026

Aug 30, 2026

Amarin analysis links Vascepa adherence to greater, longer-lasting heart benefits (AMRN:NASDAQ) - Seeking Alpha

Aug 30, 2026

Aug 28, 2026

Heart treatment linked to ~30% fewer major events; benefits may persist after stopping - Stock Titan

Aug 28, 2026

Aug 27, 2026

Amarin (NASDAQ: AMRN) sees Sarissa report 25.7M+ shares - Stock Titan

Aug 27, 2026

Aug 24, 2026

Amarin Announces REDUCE-IT-Related Presentations at ESC Congress 2026 in Munich - Quiver Quantitative

Aug 24, 2026

Aug 24, 2026

Five abstracts from an 8,179-patient study are set for the 2026 heart congress - Stock Titan

Aug 24, 2026

Aug 17, 2026

Amarin (AMRN) Holds Near $14.15 as Bulls Defend Key Support Zone - Momentum Stock Picks - careplusvn.com

Aug 17, 2026

Aug 15, 2026

Amarin Corporation Plc Sponsored ADR Revenue Breakdown – LSX:A41557 - TradingView

Aug 15, 2026

Jul 29, 2026

Earnings call transcript: Amarin Q2 2026 revenue falls, but cash flow improves - Investing.com

Jul 29, 2026

Jul 29, 2026

Amarin Corp PLC (AMRN) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges - Yahoo Finance

Jul 29, 2026

Jul 29, 2026

Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short - TradingView

Jul 29, 2026